Brazilian health authorities on Monday approved a clinical trial for the first Covid-19 vaccine developed in the country, officials said.
The National Health Inspectorate (Anvisa) announced Monday that it had approved a clinical trial of SpiN-Tec.
SpiN-Tec is a recombinant chimeric protein developed by the Center for Vaccine Research and Production at the Federal University of Minas Gerais in southeastern Brazil.
For approval, Anvisa analyzed data from earlier phases, including nonclinical in vitro . . .